Medlab Clinical Limited (MDC.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
As of 12:13PM AEDT. Market open.
Loading interactive chart…
- Simply Wall St.
Medlab Clinical Full Year 2022 Earnings: Beats Expectations
Medlab Clinical ( ASX:MDC ) Full Year 2022 Results Key Financial Results Revenue: AU$1.54m (up 110% from FY 2021). Net...
- Simply Wall St.
What You Need To Know About Medlab Clinical Limited's (ASX:MDC) Investor Composition
Every investor in Medlab Clinical Limited ( ASX:MDC ) should be aware of the most powerful shareholder groups. Large...
- GlobeNewswire
Medlab (ASX:MDC) receives Government grant to apply NanoCelle® to an RNA nasal vaccine in collaboration with University of NSW (UNSW) and Macquarie University (MQ) to fight COVID-19 future potential epidemics
NSW Government grant received on 23rd December 2021 to develop a “no-jab” vaccine solutionMedlab collaborates with UNSW and MQ University (two leading global academic and R&D institutions)This NanoCelle® non-invasive nasal delivered vaccine is considered a “first in class” medicine delivery systemThis Government Grant & Academic collaboration solidify Medlab’s transition to a true Biotech company.Global relevance expectation is extremely highNanoCelle® as an asset is yet to be valued in any anal
© 2022 Yahoo. All rights reserved.
